Glaukos (GKOS) EBIT Growth (3y) (2017 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -3.76% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 8.39% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 1.70% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 25.88% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 7.13% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 34.83% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 75.54% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -2.70% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | -24.91% |
| 10 | Glaukos | 6.00 Bn | 5.90 Bn | 117.23 Mn | 15.57% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 15.57% |
| Dec 31, 2025 | 36.96% |
| Sep 30, 2025 | 8.85% |
| Jun 30, 2025 | 14.86% |
| Mar 31, 2025 | -60.20% |
| Dec 31, 2024 | 76.86% |
| Sep 30, 2024 | -61.81% |
| Jun 30, 2024 | -28.21% |
| Mar 31, 2024 | -49.02% |
| Dec 31, 2023 | -50.23% |
| Sep 30, 2023 | -31.38% |
| Jun 30, 2023 | 14.91% |
| Mar 31, 2023 | 14.41% |
| Dec 31, 2022 | -4.34% |
| Sep 30, 2022 | -20.29% |
| Jun 30, 2022 | -80.61% |
| Mar 31, 2022 | 91.72% |
| Dec 31, 2021 | -125.19% |
| Sep 30, 2021 | 53.11% |
| Jun 30, 2021 | -49.60% |
| Mar 31, 2021 | -47.03% |
| Dec 31, 2020 | -186.08% |
| Sep 30, 2020 | -164.54% |
| Jun 30, 2020 | -130.28% |
| Mar 31, 2020 | -459.41% |
| Dec 31, 2019 | -303.01% |
| Sep 30, 2019 | -141.32% |
| Jun 30, 2019 | -70.32% |
| Mar 31, 2019 | -72.40% |
| Dec 31, 2018 | 43.36% |
| Sep 30, 2018 | -59.02% |
| Jun 30, 2018 | 7.58% |
| Mar 31, 2018 | -46.39% |
| Dec 31, 2017 | 28.18% |
| Sep 30, 2017 | 33.84% |
| Jun 30, 2017 | -19.87% |
| Mar 31, 2017 | 27.56% |